Alarin and Adipsin, which play an important role in the pathophysiology of diabetes and obesity, and have a regulatory role in hyperglycemia and insulin resistance, can be considered for use in the treatment of diabetes and associated complications. This evidence concerns the gene CFD and Hyperglycemia.